<DOC>
	<DOC>NCT01426113</DOC>
	<brief_summary>The purpose of this study is to assess the safety and efficacy of a new formulation of bimatoprost ophthalmic solution compared to timolol ophthalmic solution in the treatment of paediatric patients with glaucoma.</brief_summary>
	<brief_title>A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Diagnosis of congenital, juvenile glaucoma Requires treatment with IOPlowering medication in one or both eyes Surgical intervention is indicated or planned to lower IOP Abnormally low body weight (below 5th percentile) Any active eye infection or disease Anticipated use of contact lenses during the study Topical ocular steroid use within 2 months History of ocular trauma in either eye Required chronic use of ocular medications (other than study medication) during the study (intermittent use of artificial tears permitted)</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>